Primary record
2,4-difluoro-N-(2-(methyloxy)-5-(4-(4-pyridazinyl)-6-quinolinyl)-3-pyridinyl)benzenesulfonamide
- 库存
- 9,606 克
- 纯度
- 98.3 %
- CAS
- 1086062-66-9
化合物标识与属性
- CAS
- 1086062-66-9
- PubChem CID
- 25167777
- SMILES
- COC1=C(C=C(C=N1)C2=CC3=C(C=CN=C3C=C2)C4=CN=NC=C4)NS(=O)(=O)C5=C(C=C(C=C5)F)F
- Canonical SMILES
- COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F
名称与同义词
- Omipalisib
- GSK2126458
- 1086062-66-9
- omipalisibum
- GSK-2126458
- Omipalisib?
- GSK 2126458
- GSK212
- GSK-212
- Omipalisib [USAN:INN]
- OMIPALISIB [INN]
- Omipalisib (USAN/INN)
- RefChem:856774
- 1X8F5A3NA0
- GSK458
- OMIPALISIB [USAN]
- UNII-1X8F5A3NA0
- cc-65
- D03EZE
- GSK 212
- OMIPALISIB [WHO-DD]
- MFCD16038929
- C25H17F2N5O3S
- 2,4-difluoro-N-(2-methoxy-5-(4-(pyridazin-4-yl)quinolin-6-yl)pyridin-3-yl)benzenesulfonamide
- CHEBI:95093
- MLS006011258
- Omipalisib; GSK2126458
- SCHEMBL623194
- DTXSID10148604
- GSK-458
- GTPL8974
- orb1307306
- GSK 2126458; Omipalisib
- Omipalisib (GSK2126458)
- CHEMBL1236962
- DTXCID0071095
- SCHEMBL29352875
- SCHEMBL29358168
- EX-A003
- GSK 458
- SYN1126
- 3l08
- CGBJSGAELGCMKE-UHFFFAOYSA-N
- GLXC-90092
- HMS3656D09
- GSK2126458 (GSK458)
- AOB87781
- BCP02252
- ABP000103
- BDBM50145416
- NSC764092
- NSC800807
- s2658
- ZINC43208634
- 2,4-difluoro-N-[2-methoxy-5-(4-pyridazin-4-ylquinolin-6-yl)pyridin-3-yl]benzenesulfonamide
- AKOS015904655
- Omipalisib (GSK2126458, GSK458)
- CCG-264973
- CS-0085
- DB12703
- FD43337
- NSC-764092
- NSC-800807
- QC-7243
- RL00368
- SB16572
- SDCCGSBI-0654406.P001
- NCGC00250408-01
- NCGC00250408-05
- 4CA-0591
- AC-28458
- AK-55828
- AN-17171
- AS-16266
- BC638723
- BP-14100
- CID:25167777
- HY-10297
- SC-85404
- SMR004703011
- SID:160778570
- AB0033735
- SK2126458
- A8556
- FT-0669061
- NS00072582
- SW219502-1
- X7449
- J3.800.935D
- KS-00000635
- A11035
- A25172
- D10718
- GSK-2126458;GSK 2126458; Omipalisib
- W-5626
- 2,4-Difluoro-N-[2-methoxy-5-[4-(4-pyridazinyl)-6-quinolinyl]-3-pyridinyl]benzenesulfonamide
- C561454
- 2,4-difluoro-N-(2-(methyloxy)-5-(4-(4-pyridazinyl)-6-quinolinyl)-3-pyridinyl)benzenesulfonamide
- Benzenesulfonamide, 2,4-difluoro-N-(2-methoxy-5-(4-(4-pyridazinyl)-6-quinolinyl)-3-pyridinyl)-
- BRD-K07972848-001-02-0
- I14-17004
- Q27088179
- 2,4-difluoro-N-{2-methoxy-5-[4-(pyridazin-4-yl)quinolin-6-yl]pyridin-3-yl}benzenesulfonamide
- 2,4-difluoro-N-{2-methoxy-5-[4-(pyridazin-4-yl)quinolin-6-yl]pyridin-3-yl}benzene-1-sulfonamide
- 1-Propanone,1-[1-[(4-methoxyphenyl)methyl]-1H-pyrazol-4-yl]-
- 2,4-difluoro-N-[2-methoxy-5-(4-pyridazin-4-yl-6-quinolyl)-3-pyridyl]benzenesulfonamide
- 2,4-difluoro-N-(2-methoxy-5-(4-pyridazin-4-ylquinolin-6-yl)pyridin-3-yl)benzenesulfonamide
- N-[2-Methoxy-5-[4-(4-pyridazinyl)-6-quinolinyl]-3-pyridinyl]benzenesulfonamide
- Omipalisib, 98%, a highly selective and potent inhibitor of PI3K - 10MG 10mg
- 1105039-60-8
- 2,4-difluoro-N-{2-(methyloxy)-5-[4-(4-pyridazinyl)-6-quinolinyl]-3-pyridinyl}benzenesulfonamide
- ZIG